FGFR2 and neoplasm: For example, the naturally active compound formononetin (25 μΜ) suppresses tumor growth and angiogenesis in MCF‐7 and MDA‐MB‐231 tumor models by targeting the FGFR2‐mediated Akt signaling pathway.101